» Articles » PMID: 35852258

Financial Burden Among Cancer Patients: A National-level Perspective

Overview
Journal Cancer Med
Specialty Oncology
Date 2022 Jul 19
PMID 35852258
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This research study aimed to evaluate the financial burden among older cancer patients and its corresponding risk factors. Factors such as increasing treatment costs and work limitations often lead cancer patients to bankruptcy and poor quality of life. These consequences, in turn, can cause higher mortality rates among these patients.

Methods: This retrospective cohort study utilized data from the Health Retirement Study (HRS), conducted by the University of Michigan (N = 18,109). Eligible participants had responses captured from years 2002 to 2016. Participants were classified according to any self-reported cancer diagnosis (yes or no) and were compared on the basis of financial, work, and health-related outcomes. Propensity score (PS) matching was applied to reduce the effects of potential confounding factors. Also only, individuals with an age ≥50 and ≤85 during Wave 6 were retained.

Results: Multivariate analysis with random effects revealed several indicators of financial burden when comparing participants with a cancer diagnosis to those with no history of cancer. Mean out-of-pocket costs associated with a cancer diagnosis were $1058 higher when compared to participants with no history of cancer, suggesting that even cancer patients with insurance coverage faced out-of-pocket costs. Respondents with cancer patients had higher odds of encountering financial hardship if they are facing Work Limitations (OR = 2.714), Regular use of Medications (OR = 2.518), Hospital Stays (OR = 2.858), Declining Health (OR = 2.349), or were being covered under government health insurance (OR = 5.803) than respondents who did not have cancer, or suffered from mental health issues such as Depression (OR = 0.901).

Conclusion: Cancer patients contend with increasing financial costs during their treatment. However, most newly diagnosed patients are not aware of these costs and are given few resources to handle them.

Citing Articles

Sociodemographic Disparities in Rectal Cancer Outcomes within Academic Cancer Centers.

Kim S, Shen C, El Moheb M, Cummins K, Ruff S, Witt R Ann Surg Oncol. 2025; .

PMID: 40025321 DOI: 10.1245/s10434-025-17085-3.


Evaluating the risk of comorbidity onset in elderly patients after a cancer diagnosis.

Islam M, Saif M, Alam N, Pepper S, Ratnayake I, Mudaranthakam D BMC Public Health. 2025; 25(1):640.

PMID: 39962420 PMC: 11834647. DOI: 10.1186/s12889-025-21784-7.


The financial toxicity of cancer: unveiling global burden and risk factors - a systematic review and meta-analysis.

Kitaw T, Tilahun B, Zemariam A, Getie A, Bizuayehu M, Haile R BMJ Glob Health. 2025; 10(2).

PMID: 39929536 PMC: 11815433. DOI: 10.1136/bmjgh-2024-017133.


Evaluating the Risk of Comorbidity Onset in Elderly Patients After a Cancer Diagnosis.

Islam T, Islam M, Saif M, Saif S, Alam N, Pepper S Res Sq. 2025; .

PMID: 39764109 PMC: 11702800. DOI: 10.21203/rs.3.rs-5189676/v1.


Cancer survivor preferences on the timing and content of interventions to mitigate financial toxicity associated with cancer treatment.

Huq M, Schwartz M, Derry-Vick H, Khoudary A, Sorgen L, Billini O Support Care Cancer. 2024; 32(12):778.

PMID: 39511025 PMC: 11627591. DOI: 10.1007/s00520-024-08983-5.


References
1.
Lyman G, Kuderer N . Financial Toxicity, Financial Abuse, or Financial Torture: Let's Call It What It is!. Cancer Invest. 2020; 38(3):139-142. DOI: 10.1080/07357907.2020.1735084. View

2.
Fitch M, Sharp L, Hanly P, Longo C . Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies. J Cancer Surviv. 2021; 16(2):314-328. DOI: 10.1007/s11764-021-01025-7. View

3.
Dean L, Moss S, Rollinson S, Frasso Jaramillo L, Paxton R, Owczarzak J . Patient recommendations for reducing long-lasting economic burden after breast cancer. Cancer. 2019; 125(11):1929-1940. PMC: 6508994. DOI: 10.1002/cncr.32012. View

4.
Lee M, Khan M, Salloum R . Recent Trends in Cost-Related Medication Nonadherence Among Cancer Survivors in the United States. J Manag Care Spec Pharm. 2018; 24(1):56-64. PMC: 10398090. DOI: 10.18553/jmcp.2018.24.1.56. View

5.
Sabatino S, Coates R, Uhler R, Alley L, Pollack L . Health insurance coverage and cost barriers to needed medical care among U.S. adult cancer survivors age<65 years. Cancer. 2006; 106(11):2466-75. DOI: 10.1002/cncr.21879. View